Sebastian has been with SAP procurement for over 15 years and leads the Procurement Solutions Excellence Team. The Team is responsible to implement and adopt cloud solutions for SAP`s Global Procurement Organization and move procurement towards a value adding enabler role, focusing on cloud, simplification and automation within the end to end P2P process framework. Prior to this he was managing the Procurement Operations team in SAP`s Shared Service Center, he was leading the Post Merger Integration activities, ARIBA Network and Spot Buy implementation projects.

Phillip has been central to the restructuring and change management of the procurement organisation at Takeda. Having guided the business through its transformation, Phillip will share his insights on the process, taking us through the complexities and intricacies involved in a major restructure aligned with an evolving company agenda.

Friedhelm is currently CPO for Merck, a global leader in the Pharma sector. He has held senior leadership positions at major businesses including BASF, Deutsche Post and since 2009 at Merck. Friedhelm is a strong believer in leadership, being the key differentiating factor for success and will be providing the audience this year with a new perspective on Merck’s new procurement organisation for 2016 and beyond as the business restructures. 

With F. Hoffmann-La Roche since 2014, Martin is leading the Procurement Insights and Analytics team, responsible for business intelligence, market intelligence and measuring procurement performance. In his role as business process owner in pharma for masterdata management and analytics&reporting, he is contributing to shape the process and system landscape of the future. Prior to joining Roche, Martin gained cross industry experience in senior roles in supply chain management, logistics, finance and procurement at BMW AG, Zurich Insurance Company and Swissair Group.

Matthew manages strategic global accounts headquartered in Europe. He has deep experience of supply chain strategy, operations and change management as well as procurement, both as a consultant and within industry. Matthew has worked with blue-chip clients across the commercial, financial and public sectors. Prior to GEP, he worked at BearingPoint and Celerant Consulting in London and across Europe. He has specific experience in automotive, chemicals, FMCG, life sciences, manufacturing, paper and print, and retail industries, as well as retail banking and healthcare.  

Warren Myers is a 25-year veteran of the biopharmaceutical industry experienced both as a scientist and R&D procurement leader.

Following completion of a bachelor’s degree in biology in 1984 from the University of California, Santa Barbara, Warren quickly advanced from research technician at Becton Dickinson Immunocytometry Systems, to senior scientist at Applied Immune Sciences, and Faculty Research Scientist at Indiana University School of Medicine.

Warren’s research focused on applications of cellular immunology and molecular biology to the understanding and treatment of cancer and immune system diseases. Warren joined Bayer’s biotechnology division in 1991 focusing his career on improving drug development productivity. While completing a Master’s degree in Technology Management from Pepperdine University, Warren studied Aerospace, Electronics and Automotive industry outsourcing practices as applied to the Biopharmaceuticals industry. This research enabled Warren to design Bayer’s drug development outsourcing approach.

Warren left Bayer to help Amgen establish its strategic sourcing organization. During his ten years at Amgen, Warren held positions of increasing responsibility culminating in the role of Global Head, Strategic Sourcing and Procurement for Research and Development. Notably, Warren supported conception and drove implementation of Amgen's research and development outsourcing strategies. Warren next spent several years serving the pharmaceutical industry as an independent R&D procurement consultant and as a corporate director of a global CRO.

Warren is presently Vice President and Global Head of R&D Procurement for Takeda Pharmaceuticals and is recognized for his contributions to the advancement of transformational outsourcing and supplier relationship management practices within the biotechnology and pharmaceutical industries.

As Vice President of Global R&D Procurement Michael is responsible for clinical trial outsourcing and clinical trial operations at Boehringer Ingelheim, positioning him closest to innovation in and outside the business. With Boehringer Ingelheim since 2006 Michael is a key player in the global procurement team and has a deep understanding of the processes and vision for the business’ growth. 

Expert on clinical development having held senior positions at big and medium Pharma businesses over the last 20 years, Dave is an excellent new member of the ProcureCon Healthcare speaker faculty. As R&D becomes the key differentiator for Pharma post Patent Cliff it is crucial the voice of the Clinical Development leader is clearly heard, make sure you attend Dave’s sessions on March 1.

Salvador is the Chief Procurement Officer for the 4th biggest hotel group in Europe. In his role he is responsible for defining the global purchasing strategy, negotiating the best value proposal for the company and automating the supply chain processes. Leading a global team of 45 professionals in 5 different Business Units Salvador oversees strategic sourcing through 25 different counties, and over 600 million euros (OPEX + CAPEX).

After moving around Canada and Japan for education, Karen joined Johnson and Johnson Supply Chain in 2003. After several more moves, Karen settled in Switzerland in 2007. Since 2010, Karen has held various supplier facing roles, working with some of J&J’s largest suppliers. Her latest assignment in Procurement Talent Management, brings her functional and leadership expertise together to inspire and serve J&J Procurement.

Paresh was recently promoted to the role of Chief Procurement Officer for Norgine, a mid-size Pharma business based in the UK. Previously he served as the Head of Global Indirect Procurement giving him the best possible overview of internal and external relationships at the business. No stranger to ProcureCon Healthcare Paresh will be leading discussions and offering a networking exercise on March 2nd. 

Dapo has enjoyed a long career with AstraZeneca, holding a variety of senior Operations and Commercial roles. In April 2014 Dapo assumed the role of AZ Chief Procurement Officer accountable for the company’s external spend and supplier base across the end to end value chain. 

Dapo has held a wide variety of leadership roles across the AZ business, most recently VP Global External Sourcing where she was responsible for Operation’s global supply chain related external spend; and VP Cornerstone in GMSO, where she led the development of a new set of company-wide strategic commercial capabilities, ‘the Cornerstone model and mind-set’, and led the team responsible for the Branded Generics business initiative. Previous roles included leadership of the iPR business and UK manufacturing sites and heading the International Project Management and Asset Capability Group. 

Dapo has a pharmacy degree and is a member of the Royal Pharmaceutical Society of Great Britain.

With a specialty in Vascular Pathology, Thierry practiced for many years as a physician in Emergency Medicine. Based in Paris it was a role that placed him at the frontline of secondary care medicine in the well-established French market. His move to leading a private medical care clinic in Moscow opened his eyes and experience to the world of pay-for care and treatment and the dynamics of emerging markets.

Thierry then took his training and working life expertise as a medic to become a leading figure in the healthcare industry. From Brand Team Lead, through Marketing Director to Head of Franchise, facing many strategic challenges en route on behalf of leading healthcare players including Roche, Pfizer and Takeda. 

Beyond his medical training he has immersed himself in a number of therapeutic areas, having the opportunity to launch several assets, including Respiratory, Cardio-metabolic, Oncology and anti-infective.

Having been working on both Customer and Pharma sides, helped Thierry to fully understand needs of all parties and thus provide our partners with accurate vision on how communication and information should be sent and received by our customers.

David has worked at Johnson and Johnson for 8 years currently with global remit across all three major business areas (pharma, medical devices, consumer). At the moment David is responsible for developing, building, deploying and training new processes and structures for procurement to adopt. Key challenges David is tackling right now include deploying new processes to an organisation that is constantly moving and which is currently undergoing one of J&J’s largest ever change management programs

Martin Brass co-found Blue Latitude Health in 2002 to help organisations take advantage of digital technology to build businesses, drive innovation and create engagement with customers. Fourteen years on the vision and the values of the company remain unchanged. Offering the vision of a consultancy with the creativity of an agency, Blue Latitude Health’s combination of heritage, approach and capability provides a unique perspective in healthcare marketing. Working internationally and regionally Blue Latitude Health unlocks the potential of some of the world’s most influential healthcare brands. As Managing Director, Martin drives all commercial aspects of the company and manages a team of 50 plus people, based in central London. He has extensive healthcare experience, having led significant marketing strategy, innovation and transformation projects for global Pharmaceutical Companies, including Eli Lilly, Bristol Myers Squibb, UCB and Janssen. He is passionate about creating successful and valuable partnerships for both our clients and suppliers, and continuing to build a forward thinking business, that provides a visionary outlook that’s redefining expectations of effectiveness. To find out more please email martin.brass@bluelatitude.net.

Susanna Webber is currently Vice President at MSD, having joined in April 2015. Before this she held increasingly senior roles at GM in Russia, finally leading the business as President and Managing Director. With a vast experience in supply chain leadership Susanna is an expert on how to improve business connectivity, a topic she will be discussing in detail on March 2nd. 

Ruedigar has been in the Healthcare sector for 21 years with 10 years in Clinical Research Organisations and most recently 11 years at Roche in varying roles in Clinical Services Outsourcing (Sourcing & Functional Management). Since 2012 he has been in Procurement as the Internal Business Partner for Medical Affairs.

Nik is an experienced alliance director, relationship manager, drug developer and team leader with a track record in successfully managing R+D programs at major international pharmaceutical companies. A life scientist with academic specialization in molecular and classical genetics, coupled with 20 years broad industry experience spanning the value chain from phase 0 to phase IV, Nik has a track record in contribution to organizational change initiatives.

Christine is a member of the senior procurement management team from Sanofi reporting into the CPO. In her current role she is responsible for developing procurement strategy for Western Europe with accountability for spend management across all categories and team alignment with the global procurement and business visions.

Alejandro Basso has twenty years’ experience in procurement in the Pharmaceutical Industry. 

Highly results oriented based in a solid education as an Engineer with Supply Chain Master Degree and executive education PDD (AMP) at IESE. 

Passionate about the function, with sound knowledge of Procurement and the Industry, he participates in professional organizations, international forums and symposiums, both as an attendant and as a speaker, increasing and sharing his expertise in transforming the function. 

He is highly valued as a team player, strongly relying in Team and Peers. Conciliator and optimistic, he manages and develops his network to support his team and peers obtain their goals, as well as the Company ones. 

Excellent manager of challenges and difficult situations through his personal capabilities and effective negotiation skills, together with his high robustness and resilience. 

 While keeping focus in the long term and the Company Vision, Mission and Strategy, he also leads effectively the short term.

Chad currently heads up the Global Procurement team at Parexel, the second biggest CRO in the world. Previous experience includes senior positions at SunGard and Accellent as well as consultancy leadership roles at Archstone Consulting too. Passionate about procurement Chad continues to seek out new ways to create value beyond savings for the business and improve the way procurement is integrated into the business too.

Quentin Roach is a global business leader who is recognized for his innate and proven ability to develop and implement strategic plans while building high performance teams. As a senior level executive, he serves as a catalyst for positive transformation, innovation and growth, offering a wide-range of experience in healthcare, pharmaceutical, medical device, and automotive industries. 

He is currently Chief Procurement Officer & Senior Vice President – Global Supplier Management at Merck where he is responsible for companywide expenditures in excess of $17.5B, leadership of external manufacturing operations, implementation of supplier development & performance management processes, and productivity & cash conversion management improvement initiatives. He also oversees the company’s Supplier Diversity processes which are focused on ensuring an inclusive environment for engagement of diverse and small businesses. 

He was previously with Bristol-Myers Squibb as Senior Vice President & Chief Procurement Officer and prior with Bausch & Lomb Inc., where he held positions as Vice President – Global Customer Strategy, Vice President – Global Supply Chain/Global Sourcing & Procurement and Vice President – Global Packaging Engineering. His prior work experience includes responsibilities as Chief Procurement Officer and Director of Operations for Strong Health/The University of Rochester, and positions in Procurement, Engineering, Operations Management, Sales & Marketing Planning and Quality at Delphi Corporation and General Motors Corporation. 

Quentin holds a Master of Science in Engineering Management of Technology from Arizona State University. He completed his Bachelor of Science in Industrial Engineering from Purdue University. As a lifelong learner, Quentin has completed Executive Development Programs through both the Thunderbird (The American Graduate School of International Management - Garvin School of Management) International Consortium and Columbia University. 

Quentin has been involved in a number of organizations and boards, including: the National Board of Directors for the National Black MBA Association, Judging & Selection Committee for the Deming Cup at Columbia University, Board of Directors for SCM World, Board Member for the National Association of Manufacturers, Board of Directors for the National Black College Alumni Hall of Fame, Arizona State University’s W.P. Carey College of Business - Advisory Board and the Network for Value Chain Excellence, The Institute for Supply Management – Editorial Review Board, Garth Fagan Dance Company, The Center for Youth Services, The Trumpet Awards Foundation, the Executive Leadership Council, and the National Advisory Board for the Arts Visitation Program. He was recognized as a “Top 10 Most Inspiring Leader” by Executive 50 and is a past recipient of the Rochester Business Journal’s "40 Under Forty" - recognizing the top 40 young leaders for achievements in professional and civic leadership.

Thierry has a new global remit, looking after procurement business process design at Hoffman La Roche in Europe. In this new role he is well positioned to guide you through strategies for success when turning your relationships with internal partners into new value for your business.

Capitalising on the accuracy and positioning of market analysis and data to drive critical competitive advantage . Rembert leads the team at Boehringer Ingelheim to support and guide the CPO and senior sourcing managers to better identify opportunities and make more accurate decisions. With a big focus on ‘spend under strategy’ the role of his analytics team is vital in measuring efficiency and identifying and mitigating risk and opportunity.

Andrew set up and now manages a Procurement Department for Actavis Biologics, an R&D Biopharmaceutical company based in Liverpool, as well as working on global initiatives for the parent company. Andrew’s background includes finance management and business development enabling him to effectively navigate inside the business and between different stakeholders. His additional role as Chairperson of Actavis’ Works Council brings him into contact with senior global leadership on key issues, giving Andrew a uniquely broad understanding of the business.

Debbie is a member of the key leadership team of CIPS, with responsibility for business development in EMEA. Her role brings her in close contact with senior procurement and supply chain leaders as she helps to shape and communicate learning and accreditation services offered by one of the world's best recognised providers of professional development for procurement practitioners.

Magnus Lundgren is an Executive Business Manager and globalleader with strong focus on leadership enhancement, organisational developmentand transformation as well as TCO (Total Cost of Ownership), P/L marginexpansion and cash management. Expertise within business management,manufacturing, supply chain and procurement as well as Shared Services andPurchase-To-Payment (P2P) solutions. He has worked +20 years at global Healthcare/Pharma/LifeSciences, CPG and Petrochemical companies, with focus on Strategic Procurementplus Supply Chain Management and R&D, of which the last 16 years he has spentin progressive leadership roles of strategic procurement teams for directmaterial and indirect material and services, leading up to CPO levelexperience.

He is currently Vice President Procurement at FreseniusMedical Care North America, a global leading provider of products and servicesfor people with chronic kidney failure, where he is responsible for companywidepharmaceutical expenditures in excess of $2B, whilst influencing the total $6Bcompany spend as part of the organizational transformation they are currentlyundergoing in 2016-17.

He was previously the Chief Procurement Officer at Hospira (genericsterile injectables, biosimilars and medical devices) responsible for globalprocurement ($2.5B spend and +115 people), during a year of change leading upto the Pfizer acquisition integration. Prior to that he spent 6 years with GEHealthcare as Global Sourcing Executive (biosciences, pharmaceuticals, medicaldevices and invitro diagnostics) managing $1B spend. He has lived and worked in5 countries across WE and USA.

Magnus holds a Master of Science in Chemical Engineeringfrom the Royal Institute of Technology, Stockholm, Sweden. As part of thisdegree he completed his Master’s thesis at Institut National des SciencesAppliquées (INSA) de Rouen, France in Organic Chemistry on the topic of“Contribution to the Synthesis of a New Chiral NADH Model in theBenzo[b]-1,6-naphthyridine Series”, a biomimicry of the citric acid cycle.Always pursuing personal growth and development Magnus has undergone Procter& Gamble’s globally renowned Purchasing Fundamentals, Advanced Negotiationand Category Management as well as P&G’s Brand Building training in thebeginning of his career; High Performance Coaching and Diageo Way of BrandBuilding (DWBB) at DIAGEO and later on he concluded the Finance for BusinessLeaders and Manager Development Course (MDC) at General Electric’s (GE)leadership campus in Crotonville, NY, recognizing him as a global leader andbusiness executive.

Mr Unni is a seasoned consulting professional with 13+ years of experience in Supply Chain Management & Risk, Enterprise Risk, Strategic Sourcing, Process consulting and Business development. Diversified skill sets include team management, strategic account management, client delivery, product development and P&L management. In his current role Jagdish offers pre-sales support and coordinates with the research team to develop best-in-class solutions for healthcare clients.

Richard worked as an Intensive Care Units Nurse in the UK and Saudi Arabia, before managing a Medical Centre for British Aerospace at a Saudi Arabian airbase. On returning to the UK in 1990, he joined Ciba-Geigy in Pharma sales roles, followed by Sales Management and ultimately CNS portfolio Brand Management. He moved to the CRO sector in 1997 with Covance, then Fisher in Health Economics/Reimbursement and Marketing roles respectively, then setting up a BD and Proposals unit at Quintiles before joining Daiichi-Sankyo in 2005. The subsequent ten years in clinical development outsourcing (moving to Mitsubishi Pharma’s London office in 2009) have included global and EU outsourcing responsibilities ranging from creating a new outsourcing function, to negotiating global CRO agreements and setting up global oversight structure and processes to build long-term, effective, CRO working relationships, working closely with colleagues in Japan and US offices as Global Outsourcing Lead. Joining the Pharmaceutical Contract Management Group (PCMG) industry association in 2006, Richard’s commitment to driving and sharing best practice in Clinical Development Outsourcing was further demonstrated by his role as PCMG Committee Chairman since 2012. In the remaining time available, his other interests include fast bikes, (warm weather) SCUBA diving and learning to sail!

Daniel has been at Actelion Pharmaceuticals Ltd for over 11 years and leads the Planning & Procurement Group in Technical Operations, he is in charge of 95% of the direct spending. He is responsible for forecasting and procurement for all commercial products and alliance management with several suppliers. Daniel received his Ph.D. from the University of Basel, School of Pharmacy & Ciba-Geigy AG, Basel, Pharmaceutical Development Department followed by a postdoctoral fellowship at the University of Maryland, School of Pharmacy, Baltimore MD & Ciba-Geigy Corp. Summit NJ, Pharmaceutical Development

John is a vastly experienced executive who intimately understands the pressures of building and running a business in an intensely competitive environment. He has worked in business development and management with major global corporations such as Hewlett-Packard as well as fast-growth startup companies who defined new market sectors. He has a deep understanding of procurement dynamics, and has worked with clients across many industry sectors in Europe, India, Southern Africa and North America. He has also run his own performance consulting business, created an online training programme and written a book. At EcoVadis his role is to create alliances with partners, clients and opinion formers by building relationships based on mutual value. John has a degree in Economics and Social Psychology from Loughborough University. 

He also has a wide range of interests in the arts and culture, is a keen tennis player, sports fan and life-long lover of Welsh Rugby!

Mark has a Degree in Commercial Engineering from the Free University of Brussels and has attended MBA programmes in Chicago, Harvard, INSEAD and the London Business School. 

In 2009 Mark joined Adecco as Country Manager for Belgium & Luxembourg. He was previously a founder of Professional Staffing specialist XPE Group, acquired by Adecco. Prior to this, he was responsible for Adecco's Benelux operations between 2002 and 2007. Before Mark joined the staffing industry he held various executive positions at Wang, Apple, Citibank and Scoot in France, Spain and Belgium.

Marc Tomas obtained a Medical Degree from the Free University of Brussels, Belgium. He is Board Certified in Cardiology, Sports Medicine and in Pharmaceutical Medicine.  

He is also a certified Fellow of the European Society of Cardiology, Master Coach and Business Coach, certified from the Solvay Business School, Brussels. He gained several years of experience as a cardiologist at the University Hospital Erasme, Brussels, Belgium. 

In 1990 he joined UCB as Clinical Research Physician. In 1992 he was promoted Medical Affairs and Clinical Research Manager at Synthelabo Benelux. 

In 1995 he was nominated Medical Director at Bristol-Myers Squibb Belgium and 3 years later, Director Europe, Outcomes Research. 

From January 2001 until June 2003 he was appointed as coordinator of the evaluation team of the Belgian Commission for Medicines Reimbursement. 

In June 2003 he was appointed Clinical Affairs Director Europe, Boston Scientific Int. In 2004 he moved to GSK as Medical Director Europe, Critical Care Business Unit and was promoted 3 years later Executive Medical Director, GSK Belgium. 

From January 2009 to March 2012, he became Medical & Regulatory Affairs Director, AstraZeneca Belgium and Luxemburg. 

Marc was also international consultant from 2011 to 2013 for a leading company in the field of patient compliance. From 2013 to 2014 he was Head of Medical Affairs for Biogen Idec, Belux. *

Marc is currently Managing Director of the Health Access company, a consulting organisation committed to deliver competent advices and to support public and private life science organizations. 

Health Access has been selected in 2012 by the Brussels Region to lead an innovative project, the setting up of a unique academic clinical research platform in Brussels (Belgium). 

Since 2014, Marc is Medical Affairs Manager for MSD Belgium and currently acting Medical Director. 

Since 2011 he is founding member of the Institute of Coaching Professional Association (McLean Hospital, Harvard University Affiliate), while keeping his professional expertise as a consulting cardiologist at the Erasme Academic Hospital. 

He is since 2013 visiting professor at the Faculty of Medicine, University of Namur, Belgium, delivering teaching in communication, negotiation and networking and medication & society in Biomedical Sciences. He is also the coordinator of the ACTO research group (Access to Care & Therapy Optimisation) and Chair of the Clinical Research Group of the Pôle Santé Namur